ArticleAging2021

NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway.

Wei He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.